Well Told Grants

Federal grant programs / Department of Health and Human Services

Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders (93.840)

Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders (Assistance Listing 93.840) is run by the Centers for Disease Control and Prevention, part of the Department of Health and Human Services. It awarded $3.3 million in 9 grants from fiscal 2021 to 2025, about $364,164 per award on average. 74 funding opportunities are open or forecast now.

The typical award was $251,231. Half of the 9 awards fell between $191,177 and $450,000, and they ranged from $65,596 to $1.5 million.

Key findings

What the program funds

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The Center for Translation Research and Implementation Science (CTRIS) plans, fosters, and supports late-stage research to identify promising approaches for ensuring successful integration of evidence and evidence-based interventions within clinical and public health settings, such as health centers, worksites, schools, and communities in the United States and abroad. These approaches build on the successes in fundamental discovery science and early-stage translational research to ensure findings achieve maximal benefit for people and their communities. They also will help tackle new challenges in late-stage T4 translation research—the phase in the translational research pathway that leads to general knowledge about implementing evidence and evidence-based interventions—that helps turn discoveries into improved health. CTRIS is the strategic focal point within NHLBI to catalyze opportunities for rigorous dissemination and implementation research to advance the creation, evaluation, reporting, dissemination, sustained adoption, spread, and scale of evidence-based interventions for the prevention and treatment of heart, lung, blood, and sleep disorders. CTRIS is charged with integrating the domain expertise found in all NHLBI organizational units and leveraging the NIH-wide investments in dissemination and implementation research to accomplish its mission.

From the federal Assistance Listing. Read the full listing on SAM.gov.

Open and forecast opportunities

49 more opportunities are listed with all open grants from Department of Health and Human Services.

Rules from the program listing

Who can apply

Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals, Public nonprofit institution/organization (includes institutions of higher education and hospitals), Individual/Family, Small business (less than 500 employees), Private nonprofit institution/organization (includes institutions of higher education and hospitals). Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. Only domestic, non-profit, private or public institutions may apply for NRSA Institutional Research Training Grants. An individual may apply for an NRSA or, in some cases, for a research grant if adequate facilities to perform the research are available. SBIR grants can be awarded only to United States small business concerns (entities that are independently owned and operated for profit or owned by another small business that itself is independently owned and operated for profit, or owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these and have no more than 500 employees including affiliates). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S.

Continue reading on SAM.gov

What the money can and cannot pay for

Grants may support stipends, research expenses, supplies, travel, and research training tuition as required to perform the research effort. Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research. Individual predoctoral and postdoctoral national research service awards (NRSAs) are made directly to individuals through their universities for research training in heart and vascular diseases. NRSA awards may be made to eligible institutions to enable them to appoint individuals selected by the institution for research training. Certain service and payback provisions may apply to postdoctoral individuals upon termination of the award or termination of the appointment. SBIR Phase I awards (of approximately 6 to 24 months in duration) are to establish the scientific and technical merit of the proposed research effort, and feasibility of ideas that appear to have commercial potential. Direct to Phase II SBIR awards are for projects that have been developed beyond the feasibility phase using resources other than NIH Phase I awards that meet program needs and exhibit potential for commercial application. SBIR Phase IIB awards are for promising projects that require additional time and funding to advance to commercialization as well as ultimate approval or clearance by a Federal regulatory agency .

Continue reading on SAM.gov

Matching requirements

This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.

Deadlines

Contact the headquarters or regional location, as appropriate for application deadlines

Award range and average, in the agency's words

Range of Dollar Amount: $34,623 - $1,851,680. Average Dollar Amount: $510,413.

Quoted from the program's federal Assistance Listing. The notice of funding opportunity is the official source for each competition's rules.

Funding history and past recipients

From fiscal 2021 to 2025, Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders (93.840) awarded $3.3 million across 9 grant awards, an average of $364,164 per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The Regents of the University of ColoradoColorado1$1.5 million
Indiana Department of HealthIndiana1$558,986
Minnesota Department of HealthMinnesota1$442,754
Michigan Public Health InstituteMichigan1$311,837
City of PhiladelphiaPennsylvania1$251,231
Southern Nevada Health DistNevada1$197,848
County of CharlestonSouth Carolina1$191,177
The Regents of the University of California, San FranciscoCalifornia1$150,778
Executive Office of the Governor of DelawareDelaware1$65,474

Top states: Colorado ($1.5 million), Indiana ($558,986), Minnesota ($442,754), Michigan ($311,837), South Carolina ($191,177), California ($150,778), Nevada ($95,259), Pennsylvania ($86,849), Delaware ($65,474).

Who usually wins

State and local governments received 52% of the money, colleges and universities 48%.

Recipient typeAwardsAmountShare
State and local governments7$1.8 million52%
Colleges and universities2$1.7 million48%

By state

1 state has a page for this program: those that received at least $1 million or 10 awards. It is Colorado.

Grants by recipient's state, fiscal 2021 to 2025
StateAwardsAmount
Colorado1$1.5 million
Indiana1$558,986
Minnesota1$442,754
Michigan1$311,837
South Carolina1$191,177
California1$150,778
Nevada1$95,259
Pennsylvania1$86,849
Delaware1$65,474

Award amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.